Filing Details
- Accession Number:
- 0001179110-13-013834
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-04 19:09:57
- Reporting Period:
- 2013-08-30
- Filing Date:
- 2013-09-04
- Accepted Time:
- 2013-09-04 19:09:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216923 | G Nicholas Moore | 333 Lakeside Drive Foster City CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-30 | 130,000 | $20.71 | 130,000 | No | 4 | M | Indirect | by Trust |
| Common Stock | Acquisiton | 2013-08-30 | 21,720 | $19.63 | 151,720 | No | 4 | M | Indirect | by Trust |
| Common Stock | Disposition | 2013-08-30 | 146,904 | $60.40 | 4,816 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2013-08-30 | 4,816 | $61.02 | 0 | No | 4 | S | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | by Trust |
| No | 4 | M | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options (right to buy) | Disposition | 2013-08-30 | 21,720 | $0.00 | 21,720 | $19.63 |
| Common Stock | Non-Qualified Stock Options (right to buy) | Disposition | 2013-08-30 | 130,000 | $0.00 | 130,000 | $20.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-05-11 | No | 4 | M | Indirect | |
| 0 | 2017-05-09 | No | 4 | M | Indirect |
Footnotes
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Options vest quarterly over a period of one year from the date of grant.
- Options are 100% vested on the date of grant.
- Sale prices reported for the transactions reported here range from $59.97 to $60.96. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $60.97 to $61.12. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
